Paragon Therapeutics spinout Apogee Therapeutics has filed for an initial public offering, though the company has yet to reveal how many shares of its common stock it is putting up for sale and at what price, according to an SEC filing posted Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,